# Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease

> **NCT00373815** · PHASE1 · TERMINATED · sponsor: **University Hospital Tuebingen** · enrollment: 10 (estimated)

## Conditions studied

- Graft Versus Host Disease

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT00373815
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** 2009-10
- **Target enrollment:** 10 (ESTIMATED)
- **Why stopped:** high incidence of TTP, poor recrual
- **Last updated:** 2014-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00373815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00373815, "Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00373815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*